Abstract: It had been proved that administration of sevoflurane for the first two minutes of reperfusion effectively protects the heart against reperfusion injury in rats in vivo. Our aim was to investigate the duration of effective sevoflurane administration and its underlying mechanism in isolated rat hearts exposed to global ischemia/reperfusion (I/R) injury. Adult male Sprague-Dawley rats were randomly divided into six groups (n=12): a sham-operation group, an I/R group, and four sevoflurane postconditioning groups (S2, S5, S10, and S15). In the S2, S5, S10, and S15 groups, the duration times of sevoflurane administration were 2, 5, 10, and 15 min after the onset of reperfusion, respectively. The isolated rat hearts were mounted on the Langendorff system, and after a period of equilibrium were subjected to 40 min global ischemia and 120 min reperfusion. Left ventricular (LV) hemodynamic parameters were monitored throughout each experiment and the data at 30 min of equilibrium and 30, 60, 90, and 120 min of reperfusion were analyzed. Myocardial infarct size at the end of reperfusion (n=7 in each group) and the expression of myocardial phosphorylated akt (p-akt) after 15-min reperfusion were determined in a duplicate set of six groups of rat hearts (n=5 in each group). Compared with the I/R group, the S5, S10, and S15 groups had significantly improved left ventricular end-diastolic pressure (LVEDP), left ventricular developed pressure (LVDP), and the maximal rate of rise or fall of the LV pressure (±dP/dt_max), and decreased myocardial infarct size (P<0.05), but not the S2 group. After 15 min of reperfusion, the expression of p-akt was markedly up-regulated in the S5, S10, and S15 groups compared with that in the I/R group (P<0.05), but not in the S2 group. sevoflurane postconditioning for 5 min was sufficient to activate akt and exert maximal cardioprotection against I/R injury in isolated rat hearts.

[1]Cantley, L.C., 2002. The phosphoinositide 3-kinase pathway. Science, 296(5573):1655-1657.

[2]Chen, H.T., Yang, C.X., Li, H., Zhang, C.J., Wen, X.J., Zhou, J., Fan, Y.L., Huang, T., Zeng, Y.M., 2008. Cardioprotection of sevoflurane postconditioning by activating extracellular signal-regulated kinase 1/2 in isolated rat hearts. Acta Pharmacol. Sin., 29(8):931-941.

[3]Chiari, P.C., Bienengraeber, M.W., Pagel, P.S., Krolikowski, J.G., Kersten, J.R., Warltier, D.C., 2005. Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology, 102(1):102-109.

[4]Feng, J., Fischer, G., Lucchinetti, E., Zhu, M., Bestmann, L., Jegger, D., Arras, M., Pasch, T., Perriard, J.C., Schaub, M.C., et al., 2006. Infarct-remodeled myocardium is receptive to protection by isoflurane postconditioning: role of protein kinase b/Akt signaling. Anesthesiology, 104(5):1004-1014.

[5]He, W., Zhang, F.J., Wang, S.P., Chen, G., Chen, C.C., Yan, M., 2008. Postconditioning of sevoflurane and propofol is associated with mitochondrial permeability transition pore. J. Zhejiang Univ.-Sci. B, 9(2):100-108.

[6]Inamura, Y., Miyamae, M., Sugioka, S., Domae, N., Kotani, J., 2010. Sevoflurane postconditioning prevents activation of caspase 3 and 9 through antiapoptotic signaling after myocardial ischemia-reperfusion. J. Anesth., 24(2):215-224.

[7]Kazama, T., Ikeda, K., 1988. Comparison of MAC and the rate of rise of alveolar concentration of sevoflurane with halothane and isoflurane in the dog. Anesthesiology, 68(3):435-437.

[8]Ladilov, Y.V., Balser, C., Piper, H.M., 1998. Protection of rat cardiomyocytes against simulated ischemia and reoxygenation by treatment with protein kinase C activator. Circul. Res., 82(4):451-457.

[9]Landoni, G., Biondi-Zoccai, G.G., Zangrillo, A., Bignami, E., D′Avolio, S., Marchetti, C., Calabro, M.G., Fochi, O., Guarracino, F., Tritapepe, L., et al., 2007. Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J. Cardiothorac. Vasc. Anesth., 21(4):502-511.

[10]Obal, D., Preckel, B., Scharbatke, H., Mullenheim, J., Hoterkes, F., Thamer, V., Schlack, W., 2001. One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo. Br. J. Anaesth., 87(6):905-911.

[11]Obal, D., Scharbatke, H., Barthel, H., Preckel, B., Mullenheim, J., Schlack, W., 2003. Cardioprotection against reperfusion injury is maximal with only two minutes of sevoflurane administration in rats. Can. J. Anaesth., 50(9):940-945.

[12]Pravdic, D., Mio, Y., Sedlic, F., Pratt, P.F., Warltier, D.C., Bosnjak, Z.J., Bienengraeber, M., 2010. Isoflurane protects cardiomyocytes and mitochondria by immediate and cytosol-independent action at reperfusion. Br. J. Pharmacol., 160(2):220-232.

[13]Redel, A., Stumpner, J., Tischer-Zeitz, T., Lange, M., Smul, T.M., Lotz, C., Roewer, N., Kehl, F., 2009. Comparison of isoflurane-, sevoflurane-, and desflurane-induced pre- and postconditioning against myocardial infarction in mice in vivo. Exp. Biol. Med. (Maywood), 234(10):1186-1191.

[14]Sakai, E.M., Connolly, L.A., Klauck, J.A., 2005. Inhalation anesthesiology and volatile liquid anesthetics: focus on isoflurane, desflurane, and sevoflurane. Pharmacotherapy, 25(12):1773-1788.

[15]Siegmund, B., Schlack, W., Ladilov, Y.V., Balser, C., Piper, H.M., 1997. Halothane protects cardiomyocytes against reoxygenation-induced hypercontracture. Circulation, 96(12):4372-4379.

[16]Smul, T.M., Lange, M., Redel, A., Stumpner, J., Lotz, C.A., Roewer, N., Kehl, F., 2009. Desflurane-induced cardioprotection against ischemia-reperfusion injury depends on timing. J. Cardiothorac. Vasc. Anesth., 23(5):600-606.

[17]Wallin, R.F., Regan, B.M., Napoli, M.D., Stern, I.J., 1975. Sevoflurane: a new inhalational anesthetic agent. Anesth. Analg., 54(6):758-766.

[18]Yao, Y.T., Fang, N.X., Shi, C.X., Li, L.H., 2010a. Sevoflurane postconditioning protects isolated rat hearts against ischemia-reperfusion injury. Chin. Med. J. (Engl.), 123(10):1320-1328.

[19]Yao, Y.T., Li, L.H., Chen, L., Wang, W.P., Li, L.B., Gao, C.Q., 2010b. Sevoflurane postconditioning protects isolated rat hearts against ischemia-reperfusion injury: the role of radical oxygen species, extracellular signal-related kinases 1/2 and mitochondrial permeability transition pore. Mol. Biol. Rep., 37(5):2439-2446.

[20]Yu, L.N., Yu, J., Zhang, F.J., Yang, M.J., Ding, T.T., Wang, J.K., He, W., Fang, T., Chen, G., Yan, M., 2010. Sevoflurane postconditioning reduces myocardial reperfusion injury in rat isolated hearts via activation of PI3K/Akt signaling and modulation of bcl-2 family proteins. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 11(9):661-672.

[21]Zheng, Z., Yang, M., Zhang, F., Yu, J., Wang, J., Ma, L., Zhong, Y., Qian, L., Chen, G., Yu, L., et al., 2011. Gender-related difference of sevoflurane postconditioning in isolated rat hearts: focus on phosphatidylinositol-3-kinase/akt signaling. J. Surg. Res., 170(1):e3-e9.